GlassScriptPhysician profile
Scarlett Lopez
NPI 1245008895
$913.35
in general payments reported to CMS, 2019-2025
16 companies · $913 in 2025
The $913 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $249.02 | 2025 | Farxiga, Breztri |
| Amgen INC. | $167.85 | 2025 | Evenity, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $91.38 | 2025 | Kerendia |
| Abiomed | $74.68 | 2025 | |
| Abbvie INC. | $66.72 | 2025 | |
| Antares Pharma, INC. | $37.59 | 2025 | Xyosted |
| Novo Nordisk INC | $28.22 | 2025 | Wegovy |
| Verona Pharma, INC. | $26.80 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $24.27 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $23.72 | 2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $23.46 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $21.51 | 2025 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $21.04 | 2025 | |
| Glaxosmithkline, LLC. | $20.64 | 2025 | Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.73 | 2025 | Caplyta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.72 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scarlett Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.